Connect with us


Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports – USA TODAY

A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut risk of COVID-19 by up to 80%, maker Eli Lilly announced.



post featured image

The first COVID case in the U.S. was found in January, 2020. One year later, the numbers surrounding the pandemic are alarming.
A drug developed by Eli Lilly and Company dramatically reduced the risk of developing symptomatic COVID-19 among nursing home residents, the company found.
Of 299 residents, half of whom received a placebo, those randomized to receive the drug bamlanivimab had up to an 80% lower risk of contracting COVID-19, according to a study that has not yet been published.

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Secure the retirement of your dreams with these easy moves – Fox Business
Article feature image
The Big Day: Another vacuous Netflix attempt at Indian myth-making – The Indian Express
Article feature image
Fauci says all three Covid vaccines highly effective, urges people to take shot most available – CNBC